Name: Pattern of antibiotic consumption at national level (relative use by AWaRe classification)
Creator: WHO

Antibiotic consumption at national level by AWaRe classification groups, using relative use shares. Shares are shown for antibiotic groups such as those not classified or not recommended.

Antibiotic use by AWaRe category and country in 2023 (not classified (%) / not recommended (%))

In 2023, Bangladesh had the highest value (10.7) among 65 countries.

#	Country	Value	Change
1	Bangladesh	10.7	–
1	Kenya (2021)	4.4	-60.7%
1	Mali (2022)	2.4	+380.0%
2	Nepal	10.5	-36.7%
2	Peru (2022)	0	–
2	Cyprus (2022)	0	–
2	Rwanda (2022)	0	–
2	Sweden (2021)	0	–
2	Sudan (2021)	0	–
3	Uganda	6.6	-20.5%
4	Tunisia	6.4	+204.8%
5	United Republic of Tanzania	4.7	-67.1%
6	Ukraine	3.6	+2.9%
7	China, Hong Kong Special Administrative Region	2.7	-20.6%
8	Russian Federation	2.4	+9.1%
9	Georgia	2.3	+43.8%
10	Tajikistan	1.9	-76.8%
11	Gabon	1.8	+350.0%
12	Jordan	1.7	0.0%
13	France	1.4	-22.2%
14	Senegal	1	+25.0%
14	Cote d'Ivoire	1	+66.7%
16	Zambia	0.8	–
16	Benin	0.8	-11.1%
18	Belarus	0.6	-25.0%
19	Burkina Faso	0.5	0.0%
19	Spain	0.5	-16.7%
19	Egypt	0.5	-16.7%
19	Maldives	0.5	-16.7%
23	Germany	0.4	-20.0%
24	occupied Palestinian territory, including east Jerusalem	0.3	-25.0%

Pattern of antibiotic consumption at national level (relative use by AWaRe classification)

Filters

Pattern of antibiotic consumption at national level (relative use by AWaRe classification)

Antibiotic use by AWaRe category and country in 2023 (not classified (%) / not recommended (%))

Similar Datasets

≥70% of total antibiotic use being from WHO AWaRe Access group antibiotics (70% Access target)

Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)

Total use of antibacterials expressed as DDD per 1000 inhabitants per day

Domestic private health expenditure (PVT-D) per capita in US$